Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,301,122
Closed -$34.8M 405
2014
Q4
$34.8M Sell
1,301,122
-2,420,276
-65% -$62.5M 0.53% 47
2014
Q3
$90.5M Sell
3,721,398
-1,034,001
-22% -$26.1M 1.38% 21
2014
Q2
$121M Sell
4,755,399
-1,267,511
-21% -$29.6M 1.86% 14
2014
Q1
$129M Sell
6,022,910
-104,812
-2% -$2.26M 2.17% 12
2013
Q4
$137M Buy
6,127,722
+1,555,428
+34% +$34.3M 2.2% 11
2013
Q3
$94.4M Buy
+4,572,294
New +$97.3M 1.61% 21

Other funds holding HOLX

Levin Capital Strategies's HOLX Position: Q1 2015 in Review

Levin Capital Strategies sold out of Hologic (HOLX) in Q1 2015, closing a stake of 1,301,122 shares — an estimated $34.8M sold.

Levin Capital Strategies first reported a position in HOLX in Q3 2013 and held it in 6 quarters. The position peaked at $137M in Q4 2013. 393 funds tracked by Wall St. Rank hold HOLX as of Q1 2015.

  • Levin Capital Strategies reported no remaining Hologic position as of Q1 2015 after selling out during the quarter.
  • Levin Capital Strategies sold 1,301,122 Hologic shares in Q1 2015, an estimated $34.8M.
  • Levin Capital Strategies first reported a position in Hologic in Q3 2013 and held it in 6 quarters.
  • Levin Capital Strategies's Hologic position peaked at $137M in Q4 2013.
  • 393 funds tracked by Wall St. Rank held Hologic as of Q1 2015.

Based on Levin Capital Strategies's 13F filing for Q1 2015, filed 12 May 2015.